DC vaccination-αCD40 combination therapy improves survival of pancreatic tumour-bearing mice

DENIM study presented at IMIG2021

Amphera recruits first patients to phase II study of MesoPher to treat pancreatic cancer

Amphera wins top ten list of most groundbreaking innovations in science

Amphera presents data of MesoPher and checkpoint inhibitor combination therapy to treat mesothelioma at AACR 2019

Amphera recruits first patients to pivotal phase II/III study of MesoPher to treat pleural mesothelioma

ZonMW Parel awarded to prof dr Joachim Aerts for his research on dendritic cell immunotherapy MesoPher for mesothelioma